Published Medical Literature

Everolimus Plus Bevacizumab in Recurrent Ovarian Cancer

Heat Shock Protein 90: Key Player in New Ovarian Cancer Research

Weekly Dose-Dense Paclitaxel in Ovarian Cancer: ICON8 Trial

Niraparib in Newly Diagnosed Advanced Ovarian Cancer

How Does Secondary Surgical Cytoreduction Compare With Chemotherapy for Recurrent Ovarian Cancer?

Olaparib Plus Durvalumab Treatment of BRCA-Mutant Ovarian Cancer: MEDIOLA Trial

Can Metformin Play a Role in Preventing Ovarian Cancer?

Adding Vistusertib to Paclitaxel in Platinum-Resistant Ovarian Cancer

New Imaging Method May Improve Accuracy of Classifying Peritoneal Metastases

Ovarian Cancer Exosomes Promote Niche Formation for Metastatic Growth

VELIA/GOG-3005 Trial Update on PARP Inhibitor in Ovarian Cancer

Do Intrauterine Devices Offer Benefits Beyond Contraception?

Researchers Identify Molecular Origin of Mucinous Ovarian Carcinoma

Niraparib Maintenance Versus Surveillance in Recurrent Ovarian Cancer

Posttraumatic Stress Disorder Linked to Higher Risk of Ovarian Cancer, Study Finds

Pamiparib Plus Tislelizumab Being Studied Further in Ovarian Cancer

Linking Ovarian Cancer and Cervicovaginal Microbiota

Niraparib Plus Pembrolizumab in Recurrent Platinum-Resistant Ovarian Carcinoma

Bevacizumab for Ovarian Cancer: Final Overall Survival Analysis of GOG-0218

Role of BRCA Mutation in Hypersensitivity Reactions to Chemotherapy in Ovarian Cancer

Is Adding Entinostat to Avelumab of Benefit in Treating Advanced Epithelial Ovarian Cancer?

Link Between Folate Deficiency and Olaparib Treatment in Ovarian Cancer: Case Reports

ENGOT-OV16/NOVA Trial: Niraparib Maintenance for Recurrent Ovarian Cancer

Long Noncoding RNAs in a Risk Score System for Ovarian Cancer

Ribociclib and Letrozole Combination Therapy for Ovarian and Endometrial Cancers

Targeting Ovarian Cancer With Combination of PARP Inhibitors and Senolytic Agents

Intensity-Modulated Radiotherapy and Preservation of Ovarian Function

Role of Activated Endothelial Cells in Recurrent Ovarian Cancer

Phase III Trial Results of Trebananib Combination Therapy in Ovarian Cancer

Genetic Testing for Patients With Ovarian Cancers: Can Counseling Improve Decision-Making?

Might Circulating Tumor DNA Guide Clinical Decisions in Aggressive Ovarian Cancer?

IV Versus IP Chemotherapy Plus Bevacizumab in Advanced Ovarian Cancer

Long-Term Fatigue Among Survivors of Epithelial Ovarian Cancer

QUADRA Trial: Niraparib Active in Late-Line Ovarian Cancer

Novel Microscopic Imaging System for Ovarian Tumor Surgery

AACR Special Conference: Questions to Be Answered in Ovarian Cancer Research and Treatment

Genetic Testing in Ovarian and Breast Cancer

Improving Detection of Ovarian Cancer With the CA125 Biomarker

Is Female Infertility Associated With a Higher Risk of Cancer?

Treatment With Avelumab in Resistant Ovarian Cancer

Cediranib Plus Olaparib in Relapsed Platinum-Sensitive Ovarian Cancer

Ovarian Carcinosarcoma: Update on a Rare Malignancy

Risk of Ovarian Cancer After Radical Cystectomy for Bladder Cancer

Conservative Management Approach to Benign Ovarian Cysts and Risk of Complications

Tisotumab Vedotin Exhibits Antitumor Activity in Ovarian Cancer, Among Other Cancers

Atypical Histologic Type of Ovarian Cancer and Cowden Syndrome

Costs of Surgical Care for Women With Ovarian Cancer

Using Artificial Intelligence Tool to Identify Aggressive Ovarian Cancer Cells

Maintenance Olaparib in Newly Diagnosed Advanced Ovarian Cancer

International Surveys Focus on Surgical Practice Patterns in Advanced Ovarian Cancer

PALB2 Mutation in Hereditary Breast and Ovarian Cancer

Association Between Risk of Ovarian Cancer and Ultrasonography Findings

Comparing Neoadjuvant Chemotherapy and Debulking Surgery in Advanced Tubo-Ovarian Cancers

Chemosensitivity Mediator and Immunotherapy Target Identified in Ovarian Cancer

Preclinical Study Finds HDAC Inhibitor’s Effect Tied to Immunity Status

Impact of Low-Dose Aspirin Use on Risk of Ovarian Cancer

Can Patient-Derived Ovarian Cancer Organoids Aid in Treatment Selection?

Investigating Resistance to EZH2 Inhibition in ARID1A-Mutated Ovarian Cancer Cells

Population-Level Genomic Screening for Hereditary Ovarian Cancer

Epidural Anesthesia During Primary Debulking Surgery for Advanced Ovarian Cancer

Can Ketogenic Diet Benefit Women With Gynecologic Cancer?

Do Oral Contraceptives Reduce the Risk of Ovarian Cancer?

Consensus Classifier Algorithm Developed to Aid in Tumor Subtype Identification

Alternative to Paclitaxel Under Study in Ovarian and Uterine Cancers

Niraparib Maintenance for Recurrent Ovarian Cancer: Quality-of-Life Results

Does Adding Sorafenib to Topotecan Improve Survival in Platinum-Resistant Ovarian Cancer?

Impact of Olaparib Maintenance Therapy on Outcomes in Ovarian Cancer

Early Serous Proliferations in Fallopian Tube and Advanced High-Grade Ovarian Cancer

Can Use of Analgesics Improve Survival in Women With Ovarian Cancer?

Tumor Treating Fields Combined With Paclitaxel: Safety Results From Pilot Study

Association Between Analgesic Use and Risk of Ovarian Cancer

Parameters for Dose Reduction in Niraparib Therapy for Ovarian Cancer

Novel Antibody-Drug Conjugate in Platinum-Resistant Ovarian Cancer

Does Hormone Replacement Therapy After Oophorectomy Affect Breast Cancer Risk in BRCA1-Mutation Carriers?

Disparities in Genetic Testing for Hereditary Ovarian Cancer in the United States

Patient-Centered Website Focuses on Psychosocial Issues in Patients With Ovarian Cancer

ESMO Clinical Practice Guidelines for Nonepithelial Ovarian Cancer

Does Modified IP Chemotherapy Regimen Improve Tolerability in Patients With Ovarian Cancer?

Novel Counseling Model for Genetic Testing in Patients With Ovarian Cancer

Tumor Grade and Rate of Lymph Node Metastasis in Early-Stage Ovarian Cancer

Secondary Cytoreductive Surgery for Platinum-Sensitive Epithelial Ovarian Cancer

Genetic Biomarker as Potential Predictor of Platinum Sensitivity in Serous Ovarian Tumors

Pilot Clinical Trial of Dendritic Cell Vaccination in Ovarian Cancer

Molecular Subsets of High-Grade Serous Ovarian Tumors May Impact Future Treatments

Do Some Women Inherit Ovarian Cancer From Their Fathers?

Identifying New Clinical Trial Endpoints in the Treatment of Ovarian Cancer

Familial Link Between Testicular Cancer in Men and Ovarian Cancer in Female Relatives

Population-Based Analysis of Fallopian Tube Carcinoma Rates

Prognostic Significance of Genomic Rearrangement Patterns in High-Grade Serous Ovarian Cancer

Impact of Intraperitoneal Chemotherapy on Survival in Advanced Ovarian Cancer

Paclitaxel Plus Pazopanib in Recurrent Ovarian Cancer

Rucaparib Maintenance Therapy for Platinum-Sensitive Ovarian Cancer

Does Small Cell Ovarian Cancer Respond to Immunotherapy?

Managing Toxicities With Niraparib in Maintenance Therapy for Ovarian Cancer